GPIHBP1 and the processing of triglyceride-rich lipoproteins

Clinical Lipidology

Volumn 5, Issue 4, 2010, Pages 575-582

  Beigneux, Anne P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chylomicronemia; endothelium; hypertriglyceridemia; lipoprotein lipase; mutation

Indexed keywords

BINDING PROTEIN; CYSTEINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; LIPOPROTEIN; LIPOPROTEIN LIPASE; UNCLASSIFIED DRUG;

BINDING AFFINITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BINDING; GENETIC CONSERVATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MISSENSE MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

MUS;

EID: 77955561792     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.43     Document Type: Review

References (21)

1. Beigneux AP, Davies B, Gin P et al.: Glycosylphosphatidylinositol- anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5, 279-291 (2007).
2. Young SG, Davies BS, Fong LG et al.: GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons. Curr. Opin. Lipidol. 18(4), 389-396 (2007).
3. Sukonina V, Lookene A, Olivecrona T, Olivecrona G: Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl Acad. Sci. USA 103(46), 17450-17455 (2006).
4. Sonnenburg WK, Yu D, Lee EC et al.: Glycosylphosphatidylinositol-anchored HDL-binding protein stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin like 4. J. Lipid Res. 50(12), 2421-2429 (2009).
5. Weinstein MM, Yin L, Beigneux AP et al.: Abnormal patterns of lipoprotein lipase release into the plasma in Gpihbp1-deficient mice. J. Biol. Chem. 283(50), 34511-34518 (2008).
6. Weinstein MM, Yin L, Tu Y et al.: Chylomicronemia elicits atherosclerosis in mice-brief report. Arterioscler. Thromb. Vasc. Biol. 30(1), 20-23 (2010).
7. Nordestgaard BG, Zilversmit DB: Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J. Lipid Res. 29, 1491-1500 (1988).
8. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M: Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335(12), 848-854 (1996).
9. Zhang X, Qi R, Xian X et al.: Spontaneous atherosclerosis in aged lipoprotein lipase deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ. Res. 102, 250-256 (2008).
10. Wang J, Hegele RA: Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis. 6(1), 23 (2007).
11. Gin P, Beigneux AP, Davies B et al.: Normal binding of lipoprotein lipase, chylomicrons, and Apo-AV to GPIHBP1 containing a G56R amino acid substitution. Biochim. Biophys. Acta 1771(12), 1464-1468 (2007).
12. Franssen R, Young SG, Peelman F et al.: Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ. Cardiovasc. Genet. 3(2), 169-178 (2010).
13. Olivecrona G, Ehrenborg E, Semb H et al.: Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J. Lipid Res. 51(6), 1535-1545 (2010).
14. Beigneux AP, Franssen R, Bensadoun A et al.: Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 29, 956-962 (2009).
15. Beigneux AP, Gin P, Davies BS et al.: Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase. J. Lipid Res. 49(6), 1312-1321 (2008).
16. Gin P, Yin L, Davies BSJ et al.: The acidic domain of Gpihbp1 is important for the binding of lipoprotein lipase and chylomicrons. J. Biol. Chem. 283(43), 29554-29562 (2008).
17. Beigneux AP, Davies BSJ, Bensadoun A, Fong LG, Young SG: GPIHBP1, a GPI anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J. Lipid Res. 50(Suppl.), S57-S62 (2009).
18. Beigneux AP, Weinstein MM, Davies BS et al.: GPIHBP1 and lipolysis: an update. Curr. Opin. Lipidol. 20(3), 211-216 (2009).
19. Huang Y, Fedarovich A, Tomlinson S, Davies C: Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex. Acta Crystallogr. D. Biol. Crystallogr. 63(Pt 6), 714-721 (2007).
20. Llinas P, Le Du MH, Gardsvoll H et al.: Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 24(9), 1655-1663 (2005).
21. Beigneux AP, Gin P, Davies BSJ et al.: Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase. J. Biol. Chem. 284(44), 30240-30247 (2009).